These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16215975)

  • 1. Design of a mechanism-based probe for neuraminidase to capture influenza viruses.
    Lu CP; Ren CT; Lai YN; Wu SH; Wang WM; Chen JY; Lo LC
    Angew Chem Int Ed Engl; 2005 Oct; 44(42):6888-92. PubMed ID: 16215975
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
    Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
    Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibitors as potential anti-influenza drugs.
    Bamford MJ
    J Enzyme Inhib; 1996; 10(1):1-16. PubMed ID: 8835926
    [No Abstract]   [Full Text] [Related]  

  • 4. Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase.
    Bianco A; Brufani M; Melchioni C
    Farmaco; 2001 Apr; 56(4):305-9. PubMed ID: 11421259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor.
    von Itzstein M; Wu WY; Jin B
    Carbohydr Res; 1994 Jun; 259(2):301-5. PubMed ID: 8050102
    [No Abstract]   [Full Text] [Related]  

  • 6. Tailor made sialidase inhibitors home in on influenza virus.
    Corfield T
    Glycobiology; 1993 Oct; 3(5):413-5. PubMed ID: 8286849
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding viral neuraminidase inhibition by substituted difluorosialic acids.
    Weck S; Robinson K; Smith MR; Withers SG
    Chem Commun (Camb); 2015 Feb; 51(14):2933-5. PubMed ID: 25587931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.
    Varghese JN; McKimm-Breschkin JL; Caldwell JB; Kortt AA; Colman PM
    Proteins; 1992 Nov; 14(3):327-32. PubMed ID: 1438172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialidase substrate specificity studies using chemoenzymatically synthesized sialosides containing C5-modified sialic acids.
    Cao H; Li Y; Lau K; Muthana S; Yu H; Cheng J; Chokhawala HA; Sugiarto G; Zhang L; Chen X
    Org Biomol Chem; 2009 Dec; 7(24):5137-45. PubMed ID: 20024109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 3,4-disubstituted-Neu5Ac2en derivatives as probes to investigate flexibility of the influenza virus sialidase 150-loop.
    Rudrawar S; Dyason JC; Maggioni A; Thomson RJ; von Itzstein M
    Bioorg Med Chem; 2013 Aug; 21(16):4820-30. PubMed ID: 23800724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs.
    von Itzstein M; Dyason JC; Oliver SW; White HF; Wu WY; Kok GB; Pegg MS
    J Med Chem; 1996 Jan; 39(2):388-91. PubMed ID: 8558506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities.
    Li J; Zheng M; Tang W; He PL; Zhu W; Li T; Zuo JP; Liu H; Jiang H
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5009-13. PubMed ID: 16876409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of aromatic inhibitors of influenza virus neuraminidase.
    Jedrzejas MJ; Singh S; Brouillette WJ; Laver WG; Air GM; Luo M
    Biochemistry; 1995 Mar; 34(10):3144-51. PubMed ID: 7880809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
    Abu Hammad AM; Taha MO
    J Chem Inf Model; 2009 Apr; 49(4):978-96. PubMed ID: 19341295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of aromatic inhibitors of influenza virus neuraminidase.
    Luo M; Air GM; Brouillette WJ
    J Infect Dis; 1997 Aug; 176 Suppl 1():S62-5. PubMed ID: 9240697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun C; Zhang X; Huang H; Zhou P
    Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
    Kai H; Hinou H; Nishimura S
    Bioorg Med Chem; 2012 Apr; 20(8):2739-46. PubMed ID: 22410247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
    Yamashita M
    Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers seek new weapon against the flu.
    Service RF
    Science; 1997 Feb; 275(5301):756-7. PubMed ID: 9036534
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-influenza drugs: the development of sialidase inhibitors.
    von Itzstein M; Thomson R
    Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.